stocktools
Offerings // Virax Biolabs Group Ltd

VRAX offering history

Every offering-related filing in Virax Biolabs Group Ltd’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 149 filings back to Dec 27, 2021.

Last executed offering
Sep 30, 2024
424B5 — priced deal (shares or notes)
Last registration (announced)
Jul 24, 2026
F-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 24, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 31, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 18, 2025F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Sep 30, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 23, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 22, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 20, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 15, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 5, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Mar 31, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 30, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 22, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Dec 2, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 1, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 21, 2022F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jul 21, 2022424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 1, 2022FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 30, 2022FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 30, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 27, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jun 24, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jun 7, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 11, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Apr 25, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 18, 2022F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
VRAX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full VRAX workspace →
VRAX offering FAQ

When did VRAX last execute an offering?

Per SEC filings, Virax Biolabs Group Ltd's most recent priced offering document is a 424B5 filed 2024-09-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did VRAX last announce or register an offering?

The most recent registration is a F-3 filed 2026-07-24. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.